We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
RJA
26
Raymond James & Associates
Florida
$39K +$8.72K +3,730 +17%
ProShare Advisors
27
ProShare Advisors
Maryland
$34K -$3.23K -1,380 -6%
SG Americas Securities
28
SG Americas Securities
New York
$33K -$2.97K -1,272 -5%
TRCT
29
Tower Research Capital (TRC)
New York
$32K +$50K +21,372 +21,372%
AG
30
Aperio Group
California
$30K -$5.63K -2,411 -11%
Citadel Advisors
31
Citadel Advisors
Florida
$29K -$140K -59,793 -76%
RJFSA
32
Raymond James Financial Services Advisors
Florida
$27K -$993 -425 -2%
CG
33
Cutler Group
California
$4K
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$3K
SPIA
35
Steward Partners Investment Advisory
New York
$3K
Citigroup
36
Citigroup
New York
$3K +$82 +35 +2%
Barclays
37
Barclays
United Kingdom
$2K +$3.84K +1,643 New
Deutsche Bank
38
Deutsche Bank
Germany
$1K -$45.7K -19,564 -96%
AG
39
Advisor Group
Arizona
$1K
NFG
40
Next Financial Group
Texas
$1K
QT
41
Quantamental Technologies
New York
$1K
Wells Fargo
42
Wells Fargo
California
$1K
ED
43
Exane Derivatives
France
$183
BAMCO Inc
44
BAMCO Inc
New York
-$694K -172,669 Closed
Creative Planning
45
Creative Planning
Kansas
-$409K -101,698 Closed
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
-$355K -89,000 Closed
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
-$170K -42,517 Closed
WMSA
48
Weiss Multi-Strategy Advisers
New York
-$161K -40,000 Closed
State Street
49
State Street
Massachusetts
-$155K -38,434 Closed
UBS Group
50
UBS Group
Switzerland
-$18.8K -8,030 -99%